ETR:MRK

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

€174.60

-0.15 (-0.09 %)

(As of 08/3/2021 12:00 AM ET)

Add

Compare

Today's Range

€174.20

▼

€175.40

50-Day Range

€143.35

▼

€174.75

52-Week Range

€107.50

▼

€174.70

Volume219,526 shs

Average VolumeN/A

Market Capitalization$22.57 billion

P/E Ratio33.33

Dividend Yield0.81%

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

About MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Stock Price Up 0.6%
July 30, 2021 | americanbankingnews.com

Treasuries Give Back Ground Amid Optimism About Vaccines
March 5, 2021 | finanznachrichten.de

Merck KGaA to Host Earnings Call
March 4, 2021 | finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien's (MKGAF) Management on Q3 2020 Results - Earnings Call Transcript
November 13, 2020 | seekingalpha.com

MERCK Kommanditgesellschaft auf Aktien (MRKC.SG)
October 16, 2020 | ca.finance.yahoo.com

Merck's head of research & development announces retirement
October 2, 2020 | seekingalpha.com

Merck Research Laboratories President bids adieu
October 2, 2020 | seekingalpha.com

Merck (MRK) Presents at ESMO Virtual Congress - Slideshow
September 25, 2020 | seekingalpha.com

Merck announces encouraging data on three pipeline candidates at ESMO
September 21, 2020 | seekingalpha.com

Merck’s Keytruda delays recurrence and distant metastasis vs. placebo in skin cancer
September 21, 2020 | seekingalpha.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ETR
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolETR:MRK
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.merckgroup.com
Phone49 6151 72 0
Employees57,850
Year FoundedN/A

Sales & Book Value

Annual Sales$17.80 billion
Price / Sales1.27
Cash Flow€5.33 per share
Price / Cash Flow32.75
Book Value€43.56 per share
Price / Book4.01

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares129,242,000
Market Cap$22.57 billion
Next Earnings Date8/5/2021 (Estimated)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.15 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for MERCK Kommanditgesellschaft auf Aktien.

4.9 Community Rank

Outperform Votes
MERCK Kommanditgesellschaft auf Aktien has received 36 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
MERCK Kommanditgesellschaft auf Aktien has received 13 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
MERCK Kommanditgesellschaft auf Aktien has received 73.47% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about MERCK Kommanditgesellschaft auf Aktien and other stocks. Vote “Outperform” if you believe MRK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
MERCK Kommanditgesellschaft auf Aktien has a dividend yield of 0.81%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
MERCK Kommanditgesellschaft auf Aktien does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of MERCK Kommanditgesellschaft auf Aktien is 26.72%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MERCK Kommanditgesellschaft auf Aktien insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of MERCK Kommanditgesellschaft auf Aktien is 33.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 20.29.
Price to Earnings Ratio vs. Sector
The P/E ratio of MERCK Kommanditgesellschaft auf Aktien is 33.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.26.
Price to Book Value per Share Ratio
MERCK Kommanditgesellschaft auf Aktien has a P/B Ratio of 4.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Frequently Asked Questions

What stocks does MarketBeat like better than MERCK Kommanditgesellschaft auf Aktien?

Wall Street analysts have given MERCK Kommanditgesellschaft auf Aktien a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MERCK Kommanditgesellschaft auf Aktien wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is MERCK Kommanditgesellschaft auf Aktien's next earnings date?

MERCK Kommanditgesellschaft auf Aktien is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for MERCK Kommanditgesellschaft auf Aktien.

How has MERCK Kommanditgesellschaft auf Aktien's stock been impacted by Coronavirus?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at €98.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MRK shares have increased by 76.9% and is now trading at €174.60.
View which stocks have been most impacted by COVID-19.

Is MERCK Kommanditgesellschaft auf Aktien a good dividend stock?

MERCK Kommanditgesellschaft auf Aktien pays an annual dividend of €1.40 per share and currently has a dividend yield of 0.81%. The dividend payout ratio of MERCK Kommanditgesellschaft auf Aktien is 26.72%. This payout ratio is at a healthy, sustainable level, below 75%.
View MERCK Kommanditgesellschaft auf Aktien's dividend history.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:

Ms. Belen Garijo Lopez M.D., Chair of Exec. Board & CEO (Age 61, Pay $5M)
Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 53, Pay $4.07M)
Dr. Kai Beckmann, CEO of Electronics & Member of the Exec. Board (Age 56, Pay $4.15M)
Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 59)
Dr. Matthias J. Heinzel, CEO of Life Science Sector & Member of Exec. Board (Age 55)
Mr. Gerhard Schmitz, Head of Global Accounting (Age 58)
Mr. Dirk Toepfer, Chief Information Officer
Mr. Constantin Fest, Head of Investor Relations (Age 44)
Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 49)
Ms. Barbara Weiland, Chief Compliance Officer (Age 47)

Who are some of MERCK Kommanditgesellschaft auf Aktien's key competitors?

Some companies that are related to MERCK Kommanditgesellschaft auf Aktien include Bausch Health Companies (BHC), Valeant Pharmaceuticals International (VRX), Canopy Growth (WEED), Hikma Pharmaceuticals (HIK), Evotec (EVT), Aphria (APHA), Aurora Cannabis (ACB), (THCX.V) (THCX), OrganiGram (OGI), HEXO (HEXO), Knight Therapeutics (GUD), HLS Therapeutics (HLS), Benchmark (BMK), Amryt Pharma (AMYT) and The Supreme Cannabis (FIRE).
View all of MRK's competitors.

What other stocks do shareholders of MERCK Kommanditgesellschaft auf Aktien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MERCK Kommanditgesellschaft auf Aktien investors own include AbbVie (ABBV), Chevron (CVX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Eli Lilly and (LLY), Medtronic (MDT), AT&T (T), Adobe (ADBE), Aldeyra Therapeutics (ALDX) and Amgen (AMGN).

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the ETR under the ticker symbol "MRK."

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MRK stock can currently be purchased for approximately €174.60.

How much money does MERCK Kommanditgesellschaft auf Aktien make?

MERCK Kommanditgesellschaft auf Aktien has a market capitalization of $22.57 billion and generates $17.80 billion in revenue each year.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 57,850 workers across the globe.

What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

The company can be reached via phone at 49 6151 72 0.

This page was last updated on 8/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here